Chronic Myelomonocytic Leukemia Active Not Recruiting Phase 3 Trials for Rigosertib (DB12146)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01241500Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess BlastsTreatment
NCT01928537Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or DecitabineTreatment